The conclusions that were drawn from our unique clinical story are as follows:
-Medical inventors and researchers are enthusiastic for the use of their experimental drugs in clinical situations.
-The weakest aspect of evidence-based medicine is the 'lack of evidence' in the related particular clinical problem. This represents a great challenge, particularly for real-life medical emergencies.
-Sometimes medical doctors have to make clinical decisions despite the lack of solid scientific evidence in the presence of urgent medical needs.
-Rat and animal studies may be the only source of evidence for human use in some medical emergencies.
-Nevertheless, the best clinical practice should rely on the best current evidence obtained through randomized controlled clinical trials. 
To the Editor,
We read the publication "Results of the Hematology Laboratory Survey: What Has Changed in Eight Years?" with great interest. Kozanoğlu et al. [1] noted that "Hematology laboratories have not been defined in the Turkish Medical Laboratories Regulation (2010, 2013), which regulates procedures and principles regarding the planning, licensing, opening, regulating, classifying, monitoring, controlling, and terminating of activities of medical laboratories". We would like to share ideas from our country in Indochina. In Thailand, there is no isolated hematology laboratory. All clinical hematology investigation is performed by a standard clinical laboratory medicine center [2] . Routine laboratory survey and quality surveillance for accreditation is the basic requirement. This might be a good way for quality control of laboratory processes. Indeed, there is a need for clinical pathologists or clinical hematologists for the management of a hematology laboratory. This is necessary for the assurance of the quality of laboratory diagnoses. The concept of isolated hematology and combination with other clinical laboratories in a single laboratory medicine unit is an
